Disc Medicine, Inc.

IRON

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-091757
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026

Summary

Type

Sell

Net shares

-7,378

% of shares

-7.97%

Amount (USD)

$486,069

Insider confidence score

28.8 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Very large scheduled sell (<10% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-02

Code

S

Net shares

-4,392.0

Price per Share

$65.52

Amount (USD)

$287,771.75

Acquired/Disposed

Disposed

Shares Owned Before

92,589.0

Shares Owned After

88,197.0

Transaction 2

Security

Common Stock

Action

Sell

Date

2026-03-02

Code

S

Net shares

-2,986.0

Price per Share

$66.41

Amount (USD)

$198,297.27

Acquired/Disposed

Disposed

Shares Owned Before

88,197.0

Shares Owned After

85,211.0

Filing's footnotes

1. These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.03 to $66.88, inclusive.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.